Q32 Bio Newsroom

Positive Outlook for Q32 Bio: Buy Rating Backed by Promising Clinical Timelines and Increased Price Target

TipRanksNov 11 01:31 ET

Wells Fargo Maintains Q32 Bio(QTTB.US) With Buy Rating, Maintains Target Price $95

Moomoo NewsNov 5 05:40 ET

Raymond James Initiates Q32 Bio at Strong Buy With $90 Price Target

MT NewswiresOct 24 08:18 ET

Oppenheimer Maintains Q32 Bio(QTTB.US) With Buy Rating, Raises Target Price to $80

Moomoo NewsOct 16 08:31 ET

Q32 Bio Initiated at Overweight by Wells Fargo

Dow JonesSep 11 09:04 ET

Q32 Bio Analyst Ratings

BenzingaSep 11 08:54 ET

Wells Fargo Initiates Q32 Bio(QTTB.US) With Buy Rating, Announces Target Price $95

Moomoo NewsSep 11 06:33 ET

Piper Sandler Maintains Q32 Bio(QTTB.US) With Buy Rating, Maintains Target Price $60

Moomoo NewsAug 23 07:33 ET

Piper Sandler Sticks to Their Buy Rating for Q32 Bio (QTTB)

TipRanksAug 23 07:10 ET

Piper Sandler Maintains Q32 Bio(QTTB.US) With Buy Rating, Raises Target Price to $60

Moomoo NewsAug 19 07:31 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (EW), Immunovant (IMVT) and Q32 Bio (QTTB)

TipRanksAug 19 07:05 ET

Analysts Are Bullish on These Healthcare Stocks: Q32 Bio (QTTB), Wave Life Sciences (WVE)

TipRanksAug 13 10:20 ET

Buy Rating on Q32 Bio: Promising Clinical Trials and Market Potential for Bempikibart

TipRanksJul 26 02:02 ET

Piper Sandler Maintains Q32 Bio(QTTB.US) With Buy Rating, Maintains Target Price $45

Moomoo NewsJul 25 07:34 ET

Q32 Bio (QTTB) Receives a Buy From Piper Sandler

TipRanksJul 25 06:57 ET

Q32 Bio (QTTB) Receives a Rating Update From a Top Analyst

TipRanksJul 12 03:19 ET

Q32 Bio Analyst Ratings

BenzingaJun 17 07:12 ET

Q32 Bio Analyst Ratings

BenzingaMay 21 08:56 ET

Buy Rating Justified by Q32 Bio's Promising Pipeline and Market Potential

TipRanksMay 21 06:41 ET

Q32 Bio (QTTB) Gets a Buy From Oppenheimer

TipRanksMay 13 08:11 ET